Resebidrag 2024 Schweiz, SWISS NORDIC BIO, 7 March

150K kr SEK

Funder	Vinnova
Recipient Organization	Nextcell Pharma Ab
Country	Sweden
Start Date	Mar 06, 2024
End Date	Mar 07, 2024
Duration	1 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	Swedish Research Council
Grant ID	`2024-00381_Vinnova`

Grant Description

Purpose and goal: ** Denna text är maskinöversatt ** Aim and objective was to present NextCell´s impressive data to a wider group of specialist investors. Expected results and effects: ** Denna text är maskinöversatt ** The outcome of completed meetings is that follow-up meetings and more detailed discussions can be initiated.

Approach and implementation: ** Denna text är maskinöversatt **

The format for Swiss Nordic Bio is well-functioning and proven. Both companies and investors seem very satisfied with the arrangement.